Mild-to-moderate chronic kidney disease predicts underutilisation of guideline-directed medical therapies in patients with acute heart failure

12 May 2024 (14:00 - 14:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Marija Polovina

University Clinical Center of Serbia, Belgrade (Serbia)

7 More presentations in this session

Presentation thumbnail

COR-1167, a new long-acting CRF2 receptor agonist, decreases congestion by improving cardiorenal function in a sheep model of worsening heart failure (WHF)

Doctor P. Janiak (Paris, FR)

Abstract Slides Video

Presentation thumbnail

Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: the PARAGLIDE-HF Trial

Doctor A. Peters (Durham, US)

Abstract Slides Video

Presentation thumbnail

The impact of intrarenal venous doppler-guided diuretic management on hospital stay

Doctor M. Passos (Amadora, PT)

Abstract Slides Video

Presentation thumbnail

Response to up-titration of therapies in patients with new-onset heart failure with and without atrial fibrillation

Ms A. Zandijk (Groningen, NL)

Abstract Slides Video

Presentation thumbnail

Heart failure early post discharge appointment: a 2.5-year single-center experience

Doctor M. Passos (Amadora, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Acute heart failure - pharmacotherapy 1

The Event

Event poster

Heart Failure 2024

12 May 2024 14:00 CET

You may be interested in

Congress Presentation

An electronic health record analysis studying differences in medication use associated with renal impairment in acute heart failure

Congress Presentation

Patients with HF and CKD

Congress Presentation

Patients with CKD/hyperkalemia

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources